THE INFLUENCE OF URIC ACID ON BONE MINERAL DENSITY IN PARKINSON’S DISEASE
M.A. Bystrytska, N.V. Grygorieva, V.V. Povoroznyuk, T.Yu. Solonenko
State Institution “D.F. Chebotarev Institute of Gerontology NAMS of Ukraine”, Kyiv, Ukraine
DOI: https://doi.org/10.15407/fz65.01.074
Abstract
The effect of uric acid on bone mineral density (BMD) and
the course of Parkinson’s disease (PD) were studied in 80
patients aged 50-80 years (39 ones in the control group and 41
persons with PD). Patients with PD have significantly lower
uric acid indices compared to control (268.78 ± 57.43 and
301.69 ± 85.45 μmol/l respectively) and it was connected with
body mass (r = 0.50, P <0.05) and body mass index (r = 0.35,
P <0.05). Unlike the control group, in patients with PD there
was a significant positive relationship between uric acid level
with BMD of the proximal femur (r = 0.35, P <0.05), upper
(r = 0.36, P<0.05) and lower extremities (r = 0.41, P<0.05) and
the total body (r = 0.41, P <0.05). Reliable negative connections
of the uric acid level and indexes of cognitive functions
(according to Unified Parkinson’s disease rating scale) have
been established (r = -0.34, P <0.05).
Keywords:
uric acid, mineral density of bone tissue, Parkinson’s disease
References
- Lin X, Zhao C, Qin A, Hong D, Liu W, Huang K, Mo J, Yu H, Wu S, Fan S. Association between serum uric acid and bone health in general population: a large and multicentre study. Oncotarget. 2015;6(34):35395-403.
CrossRef
PubMed PubMedCentral
- Cortese M, Riise T, Engeland A, Ascherio A, Bjørnevik K. Urate and the risk of Parkinson's disease in men and women. Parkinsonism Relat Disord. 2018; 52:76-82.
CrossRef
PubMed
- Wen M, Zhou B, Chen YH, Ma ZL, Gou Y, Zhang CL, Yu WF, Jiao L. Serum uric acid levels in patients with Parkinson's disease: A meta-analysis. PLoS One. 2017; 12(3):e0173731.
CrossRef
PubMed PubMedCentral
- Chen H, Mosley TH, Alonso A, Huang X. Plasma urate and Parkinson's disease in the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol. 2009; 169(9):1064-9.
CrossRef
PubMed PubMedCentral
- Kim TH, Lee JH. Serum uric acid and nigral iron deposition in Parkinson's disease: a pilot study. PloS One. 2014; 9(11): e112512.
CrossRef
PubMed PubMedCentral
- Lolekha P, Wongwan P, Kulkantrakorn K. Association between serum uric acid and motor subtypes of Parkinson's disease. J Clin Neurosci. 2015; 22(8): 1264-7.
CrossRef
PubMed
- Sakuta H, Suzuki K, Miyamoto T, Masayuki M, Numao A, Fujita H, Watanabe Y,Hirata K. Serum uric acid levels in Parkinson's disease and related disorders. Brain Behav. 2017; 7(1):e00598.
CrossRef
PubMed PubMedCentral
- Recommendations for the diagnosis and treatment of Parkinson's disease; edited by prof. I. M. Karaban. Kyiv: LLC "Medical journal" Neuronius", 2017:84. [Ukrainian].
- Tan L, Wang Y, Zhou L, Shi Y, Zhang F, Liu L, Nie S. Parkinson's disease and risk of fracture: a meta-analysis of prospective cohort studies. PLoS One. 2014; 9(4): e94379.
CrossRef
PubMed PubMedCentral
- Metta V, Sanchez T, Padmakumar C. Osteoporosis: a hidden nonmotor face of Parkinson's disease. Int Rev Neurobiol. 2017; 134:877-90.
CrossRef
PubMed
- vanden Bos F, Speelman A, Samson M, Munneke M, Bloem B, Verhaar H. Parkinson's disease and osteoporosis. Age Ageing. 2013; 42(2):156-62.
CrossRef
PubMed
Povoroznyuk V, Bystrytska M, Karaban I, Karasevich N. Gender features of bone mineral density in patients with Parkinson's disease. Pain Joints Spine. 2018; 8(1):161-166. [Ukrainian]. http://dx.doi.org/10.22141/2224- 1507.8.1.2018.130695
- Kistner A, Lhommée E, Krack P. Mechanisms of body weight fluctuations in Parkinson's disease. Front Neurol. 2014; Jun 2;5:84. doi: 10.3389/fneur.2014.00084.
CrossRef
- Tanaka K, Ogata S, Tanaka H, Omura K, Honda C; Osaka Twin Research Group, Hayakawa K. The relationship between body mass index and uric acid: a study on Japanese adult twins. Environ Health Prev Med. 2015; 20(5):347-53.
CrossRef
PubMed PubMedCentral
- Mocciaa M, Picillob M, Erroc-dR, Vitalee-f C, Longoe K, Ambonie M, Santangelog G, Palladinoh-i R, Capol G, Oreficea G, Baroneb P, Pellecchia MT. Presence and progression of non-motor symptoms in relation to uric acid in de novo Parkinson's disease. Eur J Neurol. 2015;22:93-8.
CrossRef
PubMed
- Yu Z, Zhang S, Wang D, Fan M, Gao F, Sun W, Li Z, Li S. The significance of uric acid in the diagnosis and treatment of Parkinson disease. Medicine (Baltimore). 2017; 96(45): e8502.
CrossRef
PubMed PubMedCentral
- Latourte A, Bardin T, Richette P. Uric acid and cognitive decline: a double-edge sword? Curr Opin Rheumatol. 2018; 30(2):183-7.
CrossRef
PubMed
- Dubetska GS. Hyperuricemia and structural and functional status of bone tissue (mineral density and quality) in men of all ages. Pain Joints Spine. 2014; 4(16):69-72. [Ukrainian].
- Povoroznyuk VV, Dubetska GS. Hyperuricemia, body mass index, lipid metabolism indices and bone mineral density in postmenopausal women. Probl osteol. 2013; 16(1):18-21. [Ukrainian].
- Schwarzschild MA, Ascherio A, Beal MF, Cudkowicz ME, Curhan GC et al. Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial. JAMA Neurol. 2014;71(2):141-50.
CrossRef
PubMed PubMedCentral
|